UVA LVG Seed Fund Portfolio

Ceres Nanosciences, Inc.

Ceres Nanosciences Inc. (“Ceres”) is engaged in the research, development, and commercialization of innovative sample preparation products and diagnostic tests, based on its proprietary Nanotrap® particle platform. The Nanotrap® particles capture, enrich and preserve the most valuable biomarkers, enabling early and accurate detection of diseases such as cancer, cardiac, neurological, and infectious diseases, resulting in improved patient outcomes and reduced health care costs. 

Website: http://www.ceresnano.com/


July 2018 - Ceres Nanosciences' Point-of-Care Nanotrap® Lyme Antigen Test System Granted Breakthrough Device Designation by U.S. Food and Drug Administration

May 2018 - Ceres Nanosciences reaches product development milestone for point-of-care Lyme disease test and closes on additional $5.5M of Series A funding

510Kardiac Devices, Inc.

510 Kardiac is an early stage medical device company developing novel technologies for cardiovascular surgical procedures. The company was co-founded by Dr. Scott Lim, an interventional cardiologist and the Director of the Advanced Cardiac Valve Center at the University of Virginia Health System and the company’s current CEO, Jaime Sarabia, a mechanical engineer with more than 18 years of experience in medical device ventures.


May 2018 - Heart Surgery Can be Safer, Thanks to UVA Cardiologist's New Device

Mission Secure

Mission Secure, Inc. (MSi) provides unprecedented control system cyber security visibility AND protection. The patented* MSi Platform has been conceived, developed and deployed over the past seven years by a world class team of cyber security professionals, control system engineers, PhDs, military and business experts. Our team is committed to protecting critical physical assets, and the control systems that monitor and operate them, in defense, energy and transportation.

Website: http://www.missionsecure.com/


July 2018 - ITS America Executive Summit: Cybersecurity Risk and Future of Mobility

May 2018 - Comodo Cybersecurity and MSi Unveil Integrated IT/OT/SOC Security Architecture at Hack New York City

January 2018 - Mission Secure Launches MSi Platform

August 2017 - Mission Secure Completes Fourth Successful Financing

July 2017 - Patent Awarded for MSi Platform


Discovered by UVA Professor of Cell Biology and Ophthalmology Dr. Gordon Laurie, TearSolutions' first-in-class therapy is a synthetic form of the protein lacritin which targets the root causes of dry-eye disease. 

Website: http://www.tearsolutions.com/H...


December 2017 - Charlottesville startup gets $8.5 million via Tech/Carilion venture group, Russian company

August 2017 - Dry Eye Deserves Attention

March 2017 - Novel topical peptide for dry eye tackles underlying cause of disease

January 2017 - New Dry Eye Drug is First That Aims to Treat Cause, Rather than Symptoms

January 2017 - Un-dry those eyes: New solutions to treat dry eye disease are progressing successfully

December 2015 - Tears of Joy: UVA Start-up Seeks to Bring New Eye Therapy to Millions

TypeZero Technologies, Inc.

Digital health and personalized medicine company dedicated to revolutionizing the treatment and management of type 1 and type 2 diabetes.

Website: typezero.com


Unafraid to Ask More: Diabetes